Triplet chemotherapy for malignant pericardial mesothelioma: A case report

Riichiroh Maruyama, Maki Sakai, Tomomi Nakamura, Ryuichi Suemitsu, Tatsuro Okamoto, Hiroshi Wataya, Kenichi Nishiyama, Toshiaki Kamei, Yukito Ichinose

Research output: Contribution to journalArticlepeer-review

19 Citations (Scopus)


Malignant pericardial mesothelioma (MPM) is a relatively rare neoplasm in Japan, and no standard treatment regimens have been established for this disease. A 47-year-old woman with MPM presenting with cardiac tamponade was treated using four cycles of chemotherapy consisting of cisplatin (CDDP) 40 mg/m2, gemcitabine (GEM) 800 mg/m2 and vinorelbine (VNR) 20 mg/m2 on days 1 and 8 every 4 weeks after pericardial drainage alone. The diagnosis of MPM was confirmed by an immunohistochemical procedure using either positive or negative markers of malignant mesothelioma in addition to conventional cytological examinations using pericardial effusion. The patient experienced no severe non-hematological or hematological toxicities except for grade 3 neutropenia. The patient has returned to her usual activities and has remained well for 24 months after the last chemotherapy without any evidence of disease progression.

Original languageEnglish
Pages (from-to)245-248
Number of pages4
JournalJapanese journal of clinical oncology
Issue number4
Publication statusPublished - Apr 2006
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Cancer Research


Dive into the research topics of 'Triplet chemotherapy for malignant pericardial mesothelioma: A case report'. Together they form a unique fingerprint.

Cite this